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Warburg effect was first described as a mechanism by which the tumor cells rely on glycoly-
sis to power proliferation and biosynthesis (Hsu and Sabatini, 2008). The transcription factor,
hypoxia-inducible factor–1α (HIF-1α), and the serine/threonine protein kinase, mammalian target
of rapamycin (mTOR), aremajor drivers of thismetabolic switch (Lu et al., 2002; Sun et al., 2011). In
recent years a number of reports have shown that immune cells such as monocytes, macrophages,
dendritic cell, and T cells utilize a similar mechanism during activation (Palsson-McDermott and
O’Neill, 2013). It is known that activated monocytes/macrophages switch their core metabolism
from oxidative phosphorylation to glycolysis (Rodríguez-Prados et al., 2010; Liu et al., 2012). This
process is similar to the Warburg effect in tumor cells because the activated immune cells need a
readily available source of energy for phagocytosis, oxidative burst, and biosynthetic precursors to
divide and produce cytokines.
The mechanism of such metabolic switching remains unclear but a recent article by Cheng
et al. sheds light on this crucial process (Cheng et al., 2014). They studied the mechanism by
which monocytes acquire trained immunity (Figure 1). This is a process by which monocytes
on initial stimulation undergo epigenetic programing by histone modification, leading to stronger
gene transcription upon restimulation (Netea et al., 2011). Using a model of β-glucan exposure of
macrophages and subsequent LPS stimulation they show that the macrophages undergo epigenetic
upregulation of genes expressing mTOR and glycolysis, that are targets of the transcription factor
HIF-1α. The β-glucan trained monocytes showed elevated aerobic glycolysis, reduced basal respi-
ration rate and increased glucose consumption and lactate production. This was associated with a
decrease in oxygen consumption and reduced mitochondrial capacity, consistent with a metabolic
shift from oxidative phosphorylation to glycolysis. This process occurs through the activation of
Akt-mTOR-HIF-1α pathway. Blocking of the mTOR-HIF-1α pathway by chemical inhibitors abro-
gated the trained immunity and indirect inhibition of mTOR by AICAR (an activator of adenosine
monophosphate-activated protein kinase, AMPK) had similar effects. Significantly, myeloid spe-
cific HIF1α deficient mice were not protected in a model of β-glucan induced tolerance against
S. aureus sepsis, indicating that this pathway is important for septic responses.
This important study by Cheng et al. adds to a growing number of recent stud-
ies that have demonstrated that glycolytic flux and metabolic intermediates are drivers of
immune responses. For example, macrophages exposed to LPS show a shift from oxida-
tive phosphorylation to glycolysis (Rodríguez-Prados et al., 2010); and succinate, an inter-
mediate in the TCA cycle, induced Interleukin 1beta (IL-1β) production (Tannahill et al.,
2013). In addition, Glucose transporter 1 (Glut1) mediated increase in glycolysis drives a
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FIGURE 1 | Glycolysis as metabolic basis for trained immunity.
In resting monocytes the metabolism is predominated by oxidative
phosphorylation, providing a majority of adenosine triphosphate (ATP)
as the energy source. Activated monocytes during induction of
trained immunity undergo a metabolic shift toward glycolysis, the
Warburg effect, mediated by Akt-mTOR- HIF-1α.
proinflammatory phenotype in macrophages (Freemerman et al.,
2014). The realization that oncogenesis and immune responses
have a common underlying mechanism of metabolic switching
indicates that this fundamental biological process can be a poten-
tial drug target for many diseases. An important clinical applica-
tion of the concept of metabolic switching is in the identification
of therapeutic targets in sepsis.
Sepsis, a systemic inflammatory reaction to infection, is the
leading cause of death in the world. The incidence of sepsis
worldwide is 18 million every year with 30% mortality. The
economic impact of sepsis is substantial with costs of up to
$50,000/patient and $17 billion annually in United States alone
(Slade et al., 2003; Moss, 2005). While in most cases we can con-
trol the infection with antibiotics, we lack therapies to minimize
the hyperactive inflammatory response and downstream target
injury (Lyle et al., 2014). Higher levels of lactate (product of gly-
colysis) and its slower rate of clearance during resuscitation pre-
dicts worse outcome in sepsis (Garcia-Alvarez et al., 2014). It is
commonly thought that the lactate elevation is secondary to poor
perfusion or microcirculatory disturbances, but it appears from
recent studies that the lactate is more than just a marker of cir-
culatory abnormalities and likely indicates a fundamental shift in
metabolism to a more proinflammatory glycolysis. In line with
this concept, a recent study has shown that pyruvate kinase M2-
HIF-1α mediated Warburg effect drives mortality in sepsis (Yang
et al., 2014). Our data onmacrophages indicates that preservation
of mitochondrial function under inflammatory conditions leads
to attenuated cytokine responses (Srivastava et al., 2015). The
mechanism by which metabolic switching regulates inflamma-
tory processes is a novel and promising area of research. By tar-
geting the upstream events in the inflammatory cascade we may
get effective therapies for sepsis as well as for other inflammatory
disorders.
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